Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
679.00    -5.00 (-0.73%)
Bid:
678.00
Ask:
680.00
Spread: 2.00 (0.295%)
Market Cap: £1.25b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Director/PDMR Shareholding

12 Jan 2026 17:30

RNS Number : 5855O
Volex PLC
12 January 2026
 

LEI: 213800HBLQNH5FXXGE63

12 January 2026

Volex plc

("Volex" or "the Company")

Director / PDMR Dealing

Volex plc (AIM:VLX) announces that on Thursday 8 January 2026, Sir Peter Westmacott received 31 ordinary shares of 25 pence each in the capital of the Company ("Ordinary Shares") at the reference price of 399.0 pence per share, through the scrip dividend issued on Thursday 8 January 2026, as set out in the notification of dealing form below.

 

Following this issue, Sir Peter Westmacott holds 7,890 Ordinary Shares, representing 0.004% of the ordinary issued share capital of the Company.

 

The below notification made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:

 

1

Details of the Director / person discharging managerial responsibilities / person closely associated 

a)

Name

 Peter Westmacott

 

2

Reason for the notification

a)

Position/status

Senior Non-Executive Director

b)

Initial notification / Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Volex plc

b)

LEI

213800HBLQNH5FXXGE63

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument 

Ordinary Shares of 25 pence each

Identification code 

GB0009390070

b)

Nature of the transaction

Scrip dividend issue

c)

Price(s) and volume(s) 

31 Ordinary Shares of 25 pence each at a price of 399.0 pence per Ordinary Share.

d)

Aggregated information

- Aggregated volume

See 4(c) above.

- Aggregated price

e)

Date of the transaction

8 January 2026

f)

Place of the transaction 

Outside a trading venue

 

 

 For further information please contact:

 

Volex plc

Lord Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

Chris Bedford, Group General Counsel and Company Secretary

 

+44 (0) 1256 442570 investor.relations@volex.com

 

Peel Hunt LLP - Nominated Adviser & Joint Broker

Ed AllsoppDom ConveyTom Graham

 

+44 (0)20 7418 8900

Jefferies - Joint Broker

Philip NobletSam BarnettHarry Le May

+44 (0)207 029 8000

 

Sodali & Co - Media Enquiries

James White

Nicholas Johnson

+44 (0)20 7250 1446

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDLLFFQFLFBBD
Date   Source Headline
17th Mar 20163:52 pmRNSDirector/PDMR Shareholding
26th Feb 20169:44 amRNSDirector/PDMR Shareholding
26th Feb 20167:00 amRNSTrading Statement
21st Dec 20158:00 amRNSManagement changes
27th Nov 20157:00 amRNSDirectorate Change
16th Nov 20152:46 pmRNSChange of Adviser
12th Nov 20158:00 amRNSHalf Yearly Report
11th Nov 20159:30 amRNSDirector Declaration
9th Nov 20153:37 pmRNSDirector Declaration
19th Oct 201511:41 amRNSHolding(s) in Company
15th Oct 20157:00 amRNSAppointment of Non-Executive Director
2nd Oct 20158:21 amRNSDirector/PDMR Shareholding
1st Oct 20151:11 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSDirector/PDMR Shareholding
29th Sep 20151:00 pmRNSBoard Change and Trading Update
24th Jul 201512:54 pmRNSAGM Statement
26th Jun 20157:00 amRNSAnnual Report and Notice of AGM
18th Jun 201510:18 amRNSDirector/PDMR Shareholding
11th Jun 20157:00 amRNSPreliminary results for year ended 5 April 2015
8th Jun 20159:32 amRNSDirectorate Change
26th May 201512:01 pmRNSHolding(s) in Company
15th Apr 20157:00 amRNSAppointment of Non-Executive Director
27th Mar 20157:00 amRNSTrading Update
10th Mar 201510:55 amRNSHolding(s) in Company
9th Mar 20152:30 pmRNSHolding(s) in Company
20th Feb 20153:05 pmRNSDirector/PDMR Shareholding
4th Feb 201511:02 amRNSHolding(s) in Company
4th Feb 20158:30 amRNSHolding(s) in Company
30th Dec 20147:00 amRNSDirectorate Change
19th Dec 201412:00 pmRNSDirector/PDMR Shareholding
11th Dec 20147:00 amRNSBoard Change
8th Dec 201411:48 amRNSHolding(s) in Company
14th Nov 20141:45 pmRNSHolding(s) in Company
13th Nov 20143:52 pmRNSDirector/PDMR Shareholding
13th Nov 20141:49 pmRNSDirector/PDMR Shareholding
13th Nov 20147:00 amRNSVolex plc - Half year results to 5 October 2014
31st Oct 20143:05 pmRNSHolding(s) in Company
12th Sep 20144:23 pmRNSReplacement Director/PDMR Shareholding
12th Sep 201412:33 pmRNSDirector/PDMR Shareholding
21st Aug 201411:38 amRNSHolding(s) in Company
28th Jul 201411:01 amRNSDirector/PDMR Shareholding
21st Jul 201410:17 amRNSDirector/PDMR Shareholding
18th Jul 201411:03 amRNSResult of AGM
18th Jul 20149:39 amRNSAGM Statement
15th Jul 201410:08 amRNSDirector/PDMR Shareholding
14th Jul 201411:40 amRNSHolding(s) in Company
3rd Jul 20144:47 pmRNSHolding(s) in Company
3rd Jul 20142:59 pmRNSHolding(s) in Company
1st Jul 20141:55 pmRNSResult of General Meeting
1st Jul 20147:01 amRNSPublication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.